The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2025

Filed:

Sep. 14, 2023
Applicant:

Prime Bio, Inc., North Dartmouth, MA (US);

Inventor:

Bal Ram Singh, Rehoboth, MA (US);

Assignee:

Prime Bio, Inc., North Dartmouth, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/02 (2006.01); A61K 39/00 (2006.01); A61K 39/08 (2006.01); A61K 39/395 (2006.01); A61P 31/04 (2006.01); C07K 14/19 (2006.01); C07K 14/235 (2006.01); C07K 14/33 (2006.01); C07K 14/34 (2006.01); C12N 15/62 (2006.01); C12N 15/66 (2006.01); C12N 15/70 (2006.01);
U.S. Cl.
CPC ...
A61K 39/099 (2013.01); A61K 39/0018 (2013.01); A61K 39/08 (2013.01); A61K 39/39525 (2013.01); A61P 31/04 (2018.01); C07K 14/19 (2013.01); C07K 14/235 (2013.01); C07K 14/33 (2013.01); C07K 14/34 (2013.01); C12N 15/62 (2013.01); C12N 15/66 (2013.01); C12N 15/70 (2013.01); A61K 2039/542 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/622 (2013.01);
Abstract

The present invention describes a second-generation tetanus toxoid vaccine and a process for the preparation thereof, comprising the steps of: inducing anculture OD=0.5 by adding 0.2 mM IPTG; growing the culture at 14-16° C. for 14 to 20 hours; suspending the culture in 25 mM phosphate buffer containing 200 mM sodium chloride; adding 1% of triton-X-100 to the phosphate buffer, and adding the buffer to the culture; sonicating the culture for a period of 3 minutes (at 5 sec on/off pulse) at 4° C. on cold beads; centrifuging the culture for 60 to 90 minutes; collecting and purifying a supernatant using Ni-NTA affinity column with an eluant; and combining the supernatant into a pool with contaminated bands and concentrating using Centriprep-30 centrifuge filters (30 kDa pores).


Find Patent Forward Citations

Loading…